A Review on 17-β estradiol a Potent Therapeutic Factor of Diabetic Cardiomyopathy

Journal Title: Iranian journal of diabetes and obesity (IJDO) - Year 2022, Vol 14, Issue 3

Abstract

Type 2 diabetes causes structural and functional changes in the myocardium, which is called cardiomyopathy. Diabetic cardiomyopathy (DCM) is a distinct primary disorder process, independent of coronary artery disease, which leads to heart failure in diabetic patients. Also, DCM is a multifaceted disorder that is one of the leading causes of death in elderly and postmenopausal women. Menopause is associated with decreased and stopped ovarian function, which reduces and stops the production of ovarian hormones, especially estrogen. Moreover, menopause is associated with an increased risk of cardiovascular diseases. Sex steroids such as 17-β estradiol have a variety of protective effects on many tissues in the body, including the cardiovascular system. In this article, the concept of DCM, the underlying molecular signaling pathway, and, finally, the role of 17-β estradiol as one of the most important estrogens in moderating DCM are discussed to provide a theoretical basis for in-depth study.

Authors and Affiliations

Zeinab Farhadi, Mohammad Khaksari

Keywords

Related Articles

Reduced Lung Function and Progression to Prediabetes: A ProspectiveStudy

Objective: Prediabetes is a state that people have blood glucose levels higher than normal but still not in diabetes range. There is a close relationship between impaired lung function and diabetes mellitus (DM). Reduced...

Antibody Engineering to Enhancement of Ranibizumab Binding Affinity for the Prevention and Treatment of Diabetic Retinopathy

Objective: The VEGF function blockage effectively reduces the progression of diabetic retinopathy. Ranibizumab and bevacizumab are some anti-VEGF monoclonal antibodies (mAb). Considering the importance of affinity matura...

Relationship between Changes in Serum Insulin with Hepatic Expression of PEPCK, G6Pase and HNF4α in Response to Resistance Training in Diabetic Rats with High-Fat Diet and STZ

Objective: Genetic studies indicate that available insulin influences the activity or expression of hepatic gluconeogenic genes. This study aimed to assess the effect of resistance exercise program on gluconeogenic genes...

The First Phase Registration of Type 1 Diabetes in Yazd, Iran

Objective: The aim of this study was registration of type 1 diabetes mellitus (T1DM) in Yazd (the first phase of registration). Materials and Methods: This study was a cross-sectional study on the first phase registrati...

Improvement of Glucose Homeostasis in Response to Short-Term Aerobic Training in Middle-Aged Men with Abdominal Obesity

Objective: Overweight and obesity is associated with insulin resistance and is the most important risk factor of type 2 diabetes (T2DM). In present study, we assessed glycemic profile and insulin resistance response to a...

Download PDF file
  • EP ID EP709419
  • DOI -
  • Views 69
  • Downloads 1

How To Cite

Zeinab Farhadi, Mohammad Khaksari (2022). A Review on 17-β estradiol a Potent Therapeutic Factor of Diabetic Cardiomyopathy. Iranian journal of diabetes and obesity (IJDO), 14(3), -. https://europub.co.uk/articles/-A-709419